Community pharmacy TB treatment for TB/HIV patients
Part of Immune system & allergy, Infections clinical trials.
This trial tests whether giving TB treatment through community pharmacies can improve health outcomes for people living with both TB and HIV. It aims to make treatment more convenient and support better adherence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have both TB and HIV.
- Your TB is in the lungs (pulmonary TB), not outside the lungs.
- You are currently on TB treatment for 2 months or less.
- You are on a standard first-line HIV treatment (ART) or an alternative.
- You are not planning to transfer to another health facility soon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combo pill for HIV (ainuovirine, lamivudine, and tenofovir) against a standard pill (efavirenz, lamivudine, and tenofovir) in people who have both HIV and tuberculosis. It aims to find a treatment that works well and has fewer side effects.
This trial is testing a new way to find TB in communities, using chest X-rays that are read by a computer program to spot possible TB. If you join, you'll help see if this method works better for finding TB early.
This trial looks at whether screening pregnant women with HIV for tuberculosis (TB) and offering preventive treatment can improve health for both mother and baby. It may help keep you from getting active TB and protect your health during pregnancy.
This study tests whether getting HIV care through a community program is as helpful as going to a clinic for people who just found out they have HIV. It looks at how well they stay in care and take their medicine.
This study tests whether adding HIV prevention services to routine TB household contact checks can help more people stay healthy. If you or someone you live with has TB, you may be able to join.
This trial studies a treatment plan for people who have both drug-resistant tuberculosis (TB) and HIV. It focuses on starting a specific TB medication (bedaquiline) and, if needed, HIV treatment soon after enrollment to see what approach works best.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.